Download Citation
Article Source:
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors
Leoni V,
Vannini A,
Gatta V,
Rambaldi J,
Sanapo M,
et al.
(2018)
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors.
PLOS Pathogens 14(8): e1007209.
https://doi.org/10.1371/journal.ppat.1007209